ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

BIAF bioAffinity Technologies Inc

2.08
-0.21 (-9.17%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
bioAffinity Technologies Inc BIAF 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.21 -9.17% 2.08 08:57:06
개장가 저가 고가 종가 전일 종가
2.24 2.03 2.2511 2.09 2.29
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202421:00BWbioAffinity Technologies News Update
24/04/202421:00BWbioAffinity Technologies Advances New Product Development..
09/04/202421:00BWbioAffinity Technologies Expands Campaign to Support..
01/04/202422:49BWbioAffinity Technologies Reports Fourth Quarter and Full..
09/03/202407:00EDGAR2Form 8-K - Current report
09/03/202403:15PRNUSWallachbeth Capital Announces Closing of bioAffinity..
09/03/202402:45BWbioAffinity Technologies Announces Closing of $2.5 Million..
09/03/202402:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/03/202411:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/03/202400:45PRNUSWallachBeth Capital Announces Pricing of BioAffinity..
06/03/202423:46BWbioAffinity Technologies Announces Pricing of $2.5 Million..
06/03/202407:26EDGAR2Form 8-K - Current report
05/03/202422:00BWbioAffinity Technologies Reports Accelerating Sales Growth..
21/02/202422:00BWbioAffinity Technologies News Update
06/02/202422:00BWMedical Director of Lung Innovations Network and The Lung..
03/02/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:05EDGAR2Form 8-K - Current report
30/01/202422:00BWbioAffinity Technologies In The News
25/01/202410:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202410:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202410:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/01/202422:00BWbioAffinity Technologies Announces Award of Therapeutic..
08/01/202422:00BWbioAffinity Technologies In the News
09/12/202306:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/12/202322:45EDGAR2Form 8-K - Current report
05/12/202322:00BWbioAffinity Technologies Appoints Jamie Platt, Ph.D., to its..
30/11/202323:20EDGAR2Form 8-K - Current report
30/11/202322:00BWCMS Posts Final Payment Determination for bioAffinity..
29/11/202306:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/11/202322:00BWbioAffinity Technologies VP David Elzi, Ph.D., Named to..
28/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
17/11/202307:23EDGAR2Form S-3 - Registration statement under Securities Act of..
16/11/202307:07EDGAR2Form 8-K - Current report
15/11/202322:00BWbioAffinity Technologies Teams with American Cancer Society..
15/11/202306:01BWbioAffinity Technologies Reports Third Quarter 2023..
15/11/202305:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:00BWbioAffinity Technologies Names Dallas J. Coleman as National..
04/11/202305:49EDGAR2Form 8-K/A - Current report: [Amend]
04/11/202305:45EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/10/202306:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/10/202306:27EDGAR2Form 8-K - Current report
10/10/202321:00BWbioAffinity Technologies to Present at the 8th Annual Dawson..
10/10/202319:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/09/202305:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/09/202306:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/09/202322:35GLOBEDawson James Securities Announces October Date for 8th..
21/09/202306:29EDGAR2Form S-1 - General form for registration of securities under..

최근 히스토리

Delayed Upgrade Clock